OpenAI GPT-Rosalind: The AI Model Accelerating Drug Discovery in 2026

OpenAI launched GPT-Rosalind on April 16, 2026 — a frontier AI model purpose-built for biology, drug discovery, and translational medicine research. Here is what it can do and why it matters.

Continue reading the full article on WowHow →

Originally published at https://wowhow.cloud/blogs/openai-gpt-rosalind-drug-discovery-life-sciences-ai-2026

Comments

Popular posts from this blog

How YC Startups Actually Use AI Workflows (Spoiler: It's Not Zapier)